Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
NASDAQ: PBPH · Real-Time Price · USD
24.79
-0.31 (-1.25%)
Apr 24, 2026, 4:00 PM EDT - Market closed
PBPH Holdings Information
PBPH is an equity ETF with a total of 55 individual holdings. The top holdings are Eli Lilly and Company stock at 12.74%, Johnson & Johnson at 9.14%, AbbVie at 5.84%, Roche Holding AG at 4.72%, and AstraZeneca at 4.71%.
Total Holdings
55
Top 10 Percentage
59.04%
Asset Class
Equity
ETF Category
Health
Assets
735.38M
PE Ratio
19.55
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 12.74% |
| 2 | JNJ | Johnson & Johnson | 9.14% |
| 3 | ABBV | AbbVie Inc. | 5.84% |
| 4 | SWX: ROP | Roche Holding AG | 4.72% |
| 5 | LON: AZN | AstraZeneca PLC | 4.71% |
| 6 | MRK | Merck & Co., Inc. | 4.65% |
| 7 | SWX: NOVN | Novartis AG | 4.60% |
| 8 | AMGN | Amgen Inc. | 4.36% |
| 9 | GILD | Gilead Sciences, Inc. | 4.34% |
| 10 | PFE | Pfizer Inc. | 3.96% |
| 11 | CPH: NOVO.B | Novo Nordisk A/S | 3.22% |
| 12 | BMY | Bristol-Myers Squibb Company | 3.13% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 2.88% |
| 14 | LON: GSK | GSK plc | 2.74% |
| 15 | EPA: SAN | Sanofi | 2.72% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 2.04% |
| 17 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 1.34% |
| 18 | ASX: CSL | CSL Limited | 1.33% |
| 19 | EBR: ARGX | argenx SE | 1.29% |
| 20 | ZTS | Zoetis Inc. | 1.28% |
| 21 | ETR: BAYN | Bayer Aktiengesellschaft | 1.22% |
| 22 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.08% |
| 23 | TLV: TEVA | Teva Pharmaceutical Industries Limited | 0.92% |
| 24 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 0.91% |
| 25 | EBR: UCB | UCB SA | 0.90% |
As of Apr 23, 2026